Your browser doesn't support javascript.
loading
PD-1 antibody camrelizumab for Epstein-Barr virus-positive metastatic gastric cancer: a single-arm, open-label, phase 2 trial.
Sun, Yu-Ting; Guan, Wen-Long; Zhao, Qi; Wang, De-Shen; Lu, Shi-Xun; He, Cai-Yun; Chen, Shuang-Zhen; Wang, Feng-Hua; Li, Yu-Hong; Zhou, Zhi-Wei; Xu, Rui-Hua; Qiu, Miao-Zhen.
Affiliation
  • Sun YT; Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Guan WL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Zhao Q; Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Wang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Lu SX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • He CY; Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Chen SZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Wang FH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Li YH; Department of Pathology, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Zhou ZW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Xu RH; Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
  • Qiu MZ; Department of Medical Oncology, Sun Yat-Sen University Cancer Center Guangzhou 510060, P. R. China.
Am J Cancer Res ; 11(10): 5006-5015, 2021.
Article de En | MEDLINE | ID: mdl-34765307

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Prognostic_studies Langue: En Journal: Am J Cancer Res Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Prognostic_studies Langue: En Journal: Am J Cancer Res Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique